26 April 2012 - Molecular diagnostic company MDxHealth SA (NYSE:MDXH) on Thursday announced with PLUS Diagnostics that they have entered into an agreement to co-promote MDxHealth's ConfirmMDx for Prostate Cancer in the US.

PLUS Diagnostics is a US anatomic pathology company which offer...

 

 

 

You must be logged in to view the whole article.
Click here if you require signing up